Home/Filings/4/0001104659-24-106428
4//SEC Filing

Farokhzad Omid 4

Accession 0001104659-24-106428

CIK 0001726445other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 6:50 AM ET

Size

37.1 KB

Accession

0001104659-24-106428

Insider Transaction Report

Form 4
Period: 2024-10-04
Farokhzad Omid
DirectorCEO AND CHAIR
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-10-04+878,375878,375 total
    Exercise: $2.00Exp: 2030-01-27Class A Common Stock (878,375 underlying)
  • Award

    Employee Stock Option (right to buy)

    2024-10-04+532,653532,653 total
    Exercise: $2.00Exp: 2030-07-28Class A Common Stock (532,653 underlying)
  • Award

    Employee Stock Option (right to buy)

    2024-10-04+112112 total
    Exercise: $2.00Exp: 2030-08-21Class A Common Stock (112 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-10-04532,6530 total
    Exercise: $3.47Exp: 2030-07-28Class A Common Stock (532,653 underlying)
  • Award

    Employee Stock Option (right to buy)

    2024-10-04+6565 total
    Exercise: $2.00Exp: 2030-08-21Class A Common Stock (65 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-10-0487,0000 total
    Exercise: $60.15Exp: 2031-01-31Class A Common Stock (87,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-10-04878,3750 total
    Exercise: $2.70Exp: 2030-01-27Class A Common Stock (878,375 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-10-041120 total
    Exercise: $2.70Exp: 2030-08-21Class A Common Stock (112 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-10-04650 total
    Exercise: $3.47Exp: 2030-08-21Class A Common Stock (65 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-10-04584,2650 total
    Exercise: $19.00Exp: 2030-12-02Class A Common Stock (584,265 underlying)
  • Award

    Employee Stock Option (right to buy)

    2024-10-04+584,265584,265 total
    Exercise: $2.00Exp: 2030-12-02Class A Common Stock (584,265 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-10-04650,0000 total
    Exercise: $4.59Exp: 2030-02-15Class A Common Stock (650,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2024-10-04+87,00087,000 total
    Exercise: $2.00Exp: 2031-01-31Class A Common Stock (87,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2024-10-04+650,000650,000 total
    Exercise: $2.00Exp: 2030-02-15Class A Common Stock (650,000 underlying)
Footnotes (7)
  • [F1]The shares underlying the option are fully vested are immediately exercisable.
  • [F2]The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on October 4, 2024 (the "Effective Date"). The Option Repricing applies to nonstatutory options with exercise prices greater than $2.00 per share held by all continuing employees of the Issuer as of the Effective Date.
  • [F3]Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $2.00 per share, the closing price of the Issuer's Class A common stock on the Effective Date. However, if an employee exercises a repriced option before the end of a "Retention Period" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) April 4, 2026; (ii) a Change in Control, as defined in the Issuer's Equity Incentive Plan, as amended (the "2020 Plan"); and (iii) the optionholder's death or Disability (as defined in the 2020 Plan), then the employee will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options.
  • [F4]One-fourth of the shares underlying the option vested on December 3, 2021 and the remaining shares vest in 36 equal monthly installments thereafter.
  • [F5]One-fourth of the shares underlying the option vested on February 1, 2022 and the remaining shares vest in 36 equal monthly installments thereafter.
  • [F6]The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the "Original Stock Price Hurdle") which requires that the Issuer achieve a stock price equal to or greater than 150% of the option exercise price during the period beginning on the grant date and ending on February 15, 2030 (the "Original Performance Period"). If the Original Stock Price Hurdle is achieved within the Original Performance Period, then one-fourth of the shares subject to the option vest on the date that achievement of the Original Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments.
  • [F7]The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the "Stock Price Hurdle") which requires that the Issuer achieve a stock price equal to or greater than 150% of the option exercise price during the period beginning on the Effective Date and ending on February 15, 2030 (the "Performance Period"). If the Stock Price Hurdle is achieved within the Performance Period, then one-fourth of the shares subject to the option vest on the date that achievement of the Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments.

Issuer

Seer, Inc.

CIK 0001726445

Entity typeother

Related Parties

1
  • filerCIK 0001586852

Filing Metadata

Form type
4
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 6:50 AM ET
Size
37.1 KB